Literature DB >> 13867796

Phase II trials of mitomycin C, AB-100, NSC-1026, L-sarcolysin, and meta-sarcolysin, in the treatment of multiple myeloma.

D E BERGSAGEL.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS/therapy; ANTINEOPLASTIC AGENTS/therapy; CYCLOPARAFFINS/therapy; MYELOMA, PLASMA CELL/therapy

Mesh:

Substances:

Year:  1962        PMID: 13867796

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


× No keyword cloud information.
  3 in total

1.  MELPHALAN THERAPY IN MYELOMATOSIS.

Authors:  J WALDENSTROEM
Journal:  Br Med J       Date:  1964-04-04

2.  MELPHALAN IN THE TREATMENT OF MYELOMATOSIS.

Authors:  D E SPEED; D A GALTON; A SWAN
Journal:  Br Med J       Date:  1964-06-27

Review 3.  Antineoplastic and immunosuppressive drugs. II. Therapeutic uses.

Authors:  M D Cridland
Journal:  Drugs       Date:  1972       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.